Metminco rallies on quarterly update, Pantheon Resources shares fall on drilling difficulties
A look at some of the biggest risers and fallers in London today
Company
Sareum Holdings PLC
LON:SAR
Sareum Holdings (AIM:SAR) is a clinical-stage biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer. The Company is focused on developing next generation small molecules which modify the activity of the JAK kinase family and have best-in-class potential. Its lead candidate, SDC-1801, simultaneously inhibits TYK2 and JAK1. SDC-1801 is a potential treatment for a range of autoimmune diseases, including psoriasis, and has completed Phase 1 clinical development.
239 stories · page 9 of 12
Latest preclinical data for Sareum’s cancer fighting Chk1 inhibitor impresses
"The data generated from these experiments are consistent with recent findings from our research and demonstrate that a potent and selective Chk1 inhibitor such as SRA737 can effectively synergize with sub-therapeutic doses of gemcitabine t
FTSE 100 closes a shade higher as pound strengthens ahead of rate decision
Around 4pm, the UK blue chip index rose 2 points to 7,490
Archive
Proactive news snapshot: Jersey Oil and Gas, Landore Resources, Columbus Energy Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Jersey Oil & Gas, Flying Brands, Itaconix …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot - Sphere Medical Holding, Empresaria Group, Sareum Holdings …
A glance at some of the day's highlights from the Proactive Investors newswire
Hostelworld shares jump as it swings to first half profit despite impact of terror attacks on tourism
A look at some of the top risers and fallers in London today
Full-year profits at Sareum to be better-than-expected
It was only a brief pre-close trading update, but there will be enough in it to please Sareum investors
FTSE 100 rises sharply despite Provident Financial nightmare
The FTSE 100 rose 63 points to 7,382 and the pound has slipped amid Brexit fears
Archive
Proactive end of day round-up: Amur Minerals; 88 Energy; Mosman Oil & Gas ..
A glance at some of the the small cap news on the Proactive newswire today
Fusionex shares rebound amid backlash from Standard Life on plans to cancel AIM listing
A look at the biggest risers and fallers in London today
Sareum Holdings represents UK at cancer cluster conference
Sareum is one of three companies from the UK "Golden Triangle" biotechnology cluster.
Investments and investor services
FTSE 100 ends higher on day Brexit negotiations begin
The FTSE 100 closed 60 points up at 7,523 as the government begins Brexit negotiations.
Archive
Sierra Oncology encouraged by early progress on SRA737 clinical trials
Checkpoint Kinase 1 (Chk1) is Sareum’s most advanced program; it has been licensed to Sierra Oncology.
Archive
Proactive news round-up: Eurasia Mining, Gemfields, OPG Power Ventures...
Some of the small cap stories on the Proactive newswire today
Styles&Wood Group heads higher on chipper outlook
Some of the main risers and fallers in London at 3.40pm